Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
MEDIFAST INC
Insider Daniel R. Chard of Medifast, Inc. filed a Form 4 statement regarding changes in beneficial ownership of securities on September 28, 2026. This filing serves as an official report to the SEC concerning the insider's equity transactions.…more
MEDIFAST INC
Daniel R. Chard, an executive at Medifast, Inc., has filed an SEC Form 144 to report the proposed sale of company shares. This filing serves as a standard notification of an insider's plan to dispose of their holdings.…more
MEDIFAST INC
Daniel R. Chard, an insider at Medifast, Inc., has filed an SEC Form 144 to report a proposed sale of company shares. This filing serves as a standard notification of an insider's plan to dispose of their holdings.…more
11 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Medifast Highlights 'Trilivy' Metabolic Health System for Menopause
Medifast is promoting its 'Trilivy' metabolic health system, emphasizing its scientific approach to weight management during menopause. This announcement serves as a marketing effort for an existing product line rather than a new financial catalyst.…more
●●●●●●●● ●●●●● ●●●●●●
Medifast explains the clinical reasons behind weight loss failure and promotes the efficacy of its 'Trilivy' metabolic health system. This release focuses on scientific research and brand promotion without providing new financial results or material contract updates.…more
●●●●●●●● ●●●●● ●●●●●●
Medifast emphasizes that preserving lean mass and ongoing coaching are critical for maintaining weight loss results through its 'Trilivy' metabolic health system. This announcement serves as a promotional update for existing services and lacks material catalysts such as financial performance improvements or new contracts.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.